{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T16:12:30Z","timestamp":1784563950417,"version":"3.55.0"},"reference-count":26,"publisher":"Hindawi Limited","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatologic Therapy"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1111\/dth.12295","type":"journal-article","created":{"date-parts":[[2015,10,14]],"date-time":"2015-10-14T00:43:40Z","timestamp":1444783420000},"page":"126-133","source":"Crossref","is-referenced-by-count":22,"title":["Effect of topical calcineurin inhibitors as monotherapy or combined with phototherapy for vitiligo treatment: a meta-analysis"],"prefix":"10.1155","volume":"29","author":[{"given":"Yu-Ping","family":"Dang","sequence":"first","affiliation":[{"name":"Department of Dermatology; Air Force General Hospital of People's Liberation Army; Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Air Force General Hospital of People's Liberation Army; Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ying","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Air Force General Hospital of People's Liberation Army; Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Air Force General Hospital of People's Liberation Army; Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2015,10,13]]},"reference":[{"key":"10.1111\/dth.12295-BIB0001|dth12295-cit-0001","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2165\/11537090-000000000-00000","article-title":"Vitiligo in an Italian outpatient center: a clinical and serologic study of 204 patients in Tuscany","volume":"12","author":"Berti","year":"2011","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/dth.12295-BIB0002|dth12295-cit-0002","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/exd.12372","article-title":"Role of oxidative stress and autoimmunity in onset and progression of vitiligo","volume":"23","author":"Laddha","year":"2014","journal-title":"Exp Dermatol"},{"key":"10.1111\/dth.12295-BIB0003|dth12295-cit-0003","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2133.2008.08881.x","article-title":"Guideline for the diagnosis and management of vitiligo","volume":"159","author":"Gawkrodger","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/dth.12295-BIB0004|dth12295-cit-0004","first-page":"788","article-title":"Efficacy and safety of tacrolimus and pimecrolimus ointment on vitiligo: a systematic review","volume":"9","author":"Wu","year":"2009","journal-title":"Chin J Evid Based Med"},{"key":"10.1111\/dth.12295-BIB0005|dth12295-cit-0005","first-page":"CD003263","article-title":"Interventions for vitiligo","volume":"1","author":"Whitton","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/dth.12295-BIB0006|dth12295-cit-0006","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/archderm.140.9.1065","article-title":"Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo","volume":"140","author":"Passeron","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1111\/dth.12295-BIB0007|dth12295-cit-0007","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/09546630802155057","article-title":"The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial","volume":"20","author":"Esfandiarpour","year":"2009","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/dth.12295-BIB0008|dth12295-cit-0008","doi-asserted-by":"crossref","first-page":"525","DOI":"10.4103\/0378-6323.113091","article-title":"Efficacy and tolerability of combined treatment with NB-UVB and topical tacrolimus versus NB-UVB alone in patients with vitiligo vulgaris: a randomized intra-individual open comparative trial","volume":"79","author":"Satyanarayan","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1111\/dth.12295-BIB0009|dth12295-cit-0009","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1111\/dth.12295-BIB0010|dth12295-cit-0010","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2340\/00015555-0464","article-title":"Occlusive treatment enhances efficacy of tacrolimus 0.1% ointment in adult patients with vitiligo: results of a placebo-controlled 12-month prospective study","volume":"88","author":"Hartmann","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/dth.12295-BIB0011|dth12295-cit-0011","doi-asserted-by":"crossref","unstructured":"Higgins J Green S. 2011","DOI":"10.1155\/2011\/710974"},{"key":"10.1111\/dth.12295-BIB0012|dth12295-cit-0012","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1177\/0272989X05282643","article-title":"The interpretation of random-effects meta-analysis in decision models","volume":"25","author":"Ades","year":"2005","journal-title":"Med Decis Making"},{"key":"10.1111\/dth.12295-BIB0013|dth12295-cit-0013","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jclinepi.2007.10.007","article-title":"Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses","volume":"61","author":"Brok","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1111\/dth.12295-BIB0014|dth12295-cit-0014","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1111\/dth.12295-BIB0015|dth12295-cit-0015","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1089\/pho.2011.3029","article-title":"Vitiligo treatment with monochromatic excimer light and tacrolimus: results of an open randomized controlled study","volume":"30","author":"Nistico","year":"2012","journal-title":"Photomed Laser Surg"},{"key":"10.1111\/dth.12295-BIB0016|dth12295-cit-0016","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1468-3083.2009.03138.x","article-title":"Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial","volume":"23","author":"Radakovic","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/dth.12295-BIB0017|dth12295-cit-0017","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1525-1470.2009.00914.x","article-title":"Combination of 308-nm excimer laser with topical pimecrolimus for the treatment of childhood vitiligo","volume":"26","author":"Hui-Lan","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"10.1111\/dth.12295-BIB0018|dth12295-cit-0018","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1600-0781.2010.00540.x","article-title":"Does topical tacrolimus ointment enhance the efficacy of narrowband ultraviolet B therapy in vitiligo? A left-right comparison study","volume":"26","author":"Majid","year":"2010","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1111\/dth.12295-BIB0019|dth12295-cit-0019","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1525-1470.2009.00926.x","article-title":"The efficacy of pimecrolimus 1% cream combined with microdermabrasion in the treatment of nonsegmental childhood vitiligo: a randomized placebo-controlled study","volume":"26","author":"Farajzadeh","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"10.1111\/dth.12295-BIB0020|dth12295-cit-0020","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1610-0387.2006.06124.x","article-title":"Efficacy and safety of pimecrolimus cream 1% in adult patients with vitiligo: results of a randomized, double-blind, vehicle-controlled study","volume":"4","author":"Dawid","year":"2006","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/dth.12295-BIB0021|dth12295-cit-0021","first-page":"130","article-title":"Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study","volume":"30","author":"Kawalek","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1111\/dth.12295-BIB0022|dth12295-cit-0022","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1468-3083.2011.04002.x","article-title":"Treatment of vitiligo with narrowband-UVB (TL01) combined with tacrolimus ointment (0.1%) vs. placebo ointment, a randomized right\/left double-blind comparative study","volume":"25","author":"Nordal","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/dth.12295-BIB0023|dth12295-cit-0023","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1525-1470.2000.01749.x","article-title":"Characteristics of vitiligo in Korean children","volume":"17","author":"Cho","year":"2000","journal-title":"Pediatr Dermatol"},{"key":"10.1111\/dth.12295-BIB0024|dth12295-cit-0024","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00403-009-0973-3","article-title":"Time-kinetic study of repigmentation in vitiligo patients by tacrolimus or pimecrolimus","volume":"302","author":"Lubaki","year":"2010","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/dth.12295-BIB0025|dth12295-cit-0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s40257-013-0020-1","article-title":"Topical calcineurin inhibitors and lymphoma risk: evidence update with implications for daily practice","volume":"14","author":"Siegfried","year":"2013","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/dth.12295-BIB0026|dth12295-cit-0026","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.4081\/dr.2010.e13","article-title":"Photocarcinogenicity of selected topically applied dermatological drugs: calcineurin inhibitors, corticosteroids, and vitamin D analogs","volume":"2","author":"Lerche","year":"2010","journal-title":"Dermatol Rep"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdth.12295","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/dth.12295\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T08:48:15Z","timestamp":1692089295000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dth.12295"}},"subtitle":["Effect of combined therapy for vitiligo"],"short-title":[],"issued":{"date-parts":[[2015,10,13]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"URL":"https:\/\/doi.org\/10.1111\/dth.12295","archive":["Portico"],"relation":{},"ISSN":["1396-0296"],"issn-type":[{"value":"1396-0296","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10,13]]}}}